-
Original Article
-
- Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study
-
Ruyan Zhang1
, Xiaoran Liu1, Guohong Song1, Yan Zhang2, Huiping Li1
-
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital and Institute, Beijing, China
2State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China
- Corresponding author: Huiping Li ,Tel: 86-13811012595, Email: huipingli2012@hotmail.com
- Received: October 20, 2023; Accepted: December 19, 2023.
- Abstract
-
Fatal error: Call to undefined function abstract_title() in /home/virtual/e-crt/journal/m/journal/include.m_db.php on line 196
